Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
influenza vaccine
Manufacturing
CSL’s Seqirus unit boasts bigger batch of flu vaccines
CSL Seqirus, a unit of the Australian biopharma CSL, touted the availability of more influenza vaccines in the U.S. ahead of the upcoming flu season.
Joseph Keenan
Sep 30, 2026 9:27am
Sanofi offers commitments to end EU flu shot antitrust probe
Jul 8, 2026 4:26pm
CSL details sales slide behind recent leadership transition
Feb 12, 2026 8:29am
Beleaguered CSL announces surprise CEO retirement
Feb 10, 2026 10:45am
Sanofi shrugs off policy tumult as it predicts vaccine sales dip
Jan 29, 2026 11:42am
Its future murky, CSL Seqirus opens $1B vax plant in Australia
Dec 9, 2025 9:08am